NowRX Returns to SeedInvest For Series C Funding in Reg A+ Offering
NowRX, has returned to SeedInvest for its Series C funding round. According to the offering page, NowRX is raising capital at a pre-money valuation of $275 million. The size of the round is indicative of the ability for more mature firms to raise capital online…. Read More
Read more in: Offerings | Tagged nowrx, regulation a, seedinvest